| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/10/2003 | US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/10/2003 | US20030129208 Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses |
| 07/10/2003 | US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129134 Method of monitoring neuroprotective treatment |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | CA2471635A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/10/2003 | CA2471601A1 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 07/10/2003 | CA2471531A1 Agents for treating mild cognitive impairment |
| 07/10/2003 | CA2471388A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471300A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471130A1 Il-17 like molecules and uses thereof |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2471039A1 Method of systemically delivering ssris |
| 07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | CA2470696A1 Pecam-1 modulation |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2463738A1 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 07/10/2003 | CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/09/2003 | EP1325765A1 Combinations of Formoterol and Mometasone Furoate for Asthma |
| 07/09/2003 | EP1325752A2 Composition for transdermal and/or transmucosal administration of active compounds which ensures adequate therapeutic levels |
| 07/09/2003 | EP1325747A2 Dietary supplement for neuropaths |
| 07/09/2003 | EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 07/09/2003 | EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
| 07/09/2003 | EP1325000A1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324987A1 Indazoles with thyroid hormon like activity, a process for its preparation and its use in pharmaceutical compositions |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324772A2 Methods for treating disorders of the female reproductive system |
| 07/09/2003 | EP1324757A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 07/09/2003 | EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 07/09/2003 | EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid |
| 07/09/2003 | EP0988056B1 Tissue factor methods and compositions for coagulation and tumor treatment |
| 07/09/2003 | EP0717631B1 Immunomodulating compositions from bile |
| 07/09/2003 | EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache |
| 07/09/2003 | EP0190315B2 Dehydrated liposomes |
| 07/09/2003 | CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 07/09/2003 | CN1429267A Neural progenitor cell populations |
| 07/09/2003 | CN1429232A Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1429114A 联合化学疗法 Combined chemotherapy |
| 07/09/2003 | CN1429111A Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| 07/09/2003 | CN1429109A Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1429102A Hydrogel composition for transdermal drug delivery |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/09/2003 | CN1113669C Method for treating endothelial injury |
| 07/09/2003 | CN1113653C Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/08/2003 | US6589990 Topically administering to penis to treat sexual disorder |
| 07/08/2003 | US6589987 Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and |
| 07/08/2003 | US6589965 Method of treating and preventing migraine headaches |
| 07/08/2003 | US6589962 Certain alpha -hydroxy- gamma -(((carbocyclic- or heterocyclic- substituted)amino)carbonyl)alkanamide derivatives are described as inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in |
| 07/08/2003 | US6589947 Treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist. |
| 07/08/2003 | US6589941 Preventing or reducing formation of resistance in cytostatic treatment comprising combining BVDU, a salt thereof or BVDU in protected form or in prodrug form with at least one cytostatic agent in order to prevent or reduce the formation |
| 07/08/2003 | US6589938 Cardiovascular disorders |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589759 Thrombopoietin as thrombopoiesis stimulating factor and S-nitrosoglutathione as nitiric oxide donor; use for treating and preventing blood disorders |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589747 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589566 Composition comprising theanine |
| 07/08/2003 | US6589555 Effervescence |
| 07/08/2003 | US6589548 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 07/08/2003 | US6589504 Binding or aggregating fibrils with radiolabeled quinoline-hydrazone compound |
| 07/08/2003 | US6589286 Eustachian tube stent |
| 07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2197139C A drug for the treatment of cancer |
| 07/08/2003 | CA1341434C Compositions and methods for administering therapeutically active compounds |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 07/03/2003 | WO2003054159A2 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054014A2 Apolipoprotein biopolymer markers predictive of alzheimers disease |
| 07/03/2003 | WO2003054012A2 Leptin proteins |